Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 6 years
- Director since
- 2024
6 years of board service in total across 4 boards, counting each seat separately. Longest: Q32 Bio Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Q32 Bio Inc. June 13, 202593.3%
-
OnKure Therapeutics Inc. May 27, 202583.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Addex Therapeutics Ltd | Sold back to the company | −219,561 | — | — |
| Sep 2, 2026 | Addex Therapeutics Ltd | Grant or award | +219,561 | — | — |
| Jun 30, 2026 | Q32 Bio Inc. | Option exercise | +53,521 | $2.80 | $149,859 |
| Dec 31, 2025 | OnKure Therapeutics Inc. | Grant or award | +5,258 | — | — |
| Sep 30, 2025 | OnKure Therapeutics Inc. | Grant or award | +5,545 | — | — |
| Jun 30, 2025 | OnKure Therapeutics Inc. | Grant or award | +6,311 | — | — |
| Mar 31, 2025 | OnKure Therapeutics Inc. | Grant or award | +3,469 | — | — |
Questions about Isaac Manke
What boards is Isaac Manke on?
Isaac Manke sits on the boards of Addex Therapeutics Ltd, OnKure Therapeutics Inc., Q32 Bio Inc. and Rainier Acquisition Corporation.
How long has Isaac Manke served on boards?
Our records show at least 6 years of board service across 4 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.